AB1266 REVIEW OF THE MANAGEMENT OF GOUT BY THE GENERAL PRACTITIONER

Background Gout is the most common microcrystalline arthritis. It a life-threatening disease due to joint damage, but also renal complications, which depends on adequate management of disease. Unlike other inflammatory arthritides, gout largely managed in primary care. Objectives The objective this study compare general practitioners with international recommendations. Methods For we conducted survey among 117 during 1 month. questionnaire was established form 7 clinical cases. Results Oral colchicine prescribed as first-line therapy acute access by 85.3% physicians. In 69% physicians, combined analgesics, prednisone or allopurinol. Allopurinol alone 31.9% case side effects colchicine, 49.6% recommend reducing dose 35% doctors proposed stop it, 13.7% and 11.1% replace it allopurinol an analgesic respectively. initial assessment be requested before starting allopurinol, 69.8% indicated that systematic treatment, while no necessary noted 23.3% doctors. Thirty-one physicians have therapeutic goal lowering uricemia below 50mg/l tophaceous versus 45.7% recommending level 60mg/l 4.3% suggesting 70mg/l. maximum not exceeded 900mg 47% practitioners, 300mg, 600mg 1200mg 21.4%, 17.1% 15.4% Hypo-uricemic treatment patients recurrent attacks, arthropathies, tophus radiological signs gout. Thus, 8.5% disease-modifying for recommended indications. Among things, 36.8% hypouricemic event asymptomatic hyperuricemia. Regarding patient education, majority advise weight loss (77.6%) low purine diet (75%). Conclusion This work has objectified often poorly need continuing medical education will certainly help improve practices. Reference [1]Roddy E, Zhang W, Doherty M.Concordance chronic UK primary-care population EULAR recommendations,Ann Rheum Dis 2007 66: 1311-1315. Acknowledgements: NIL. Disclosure Interests None Declared.